S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Fed's Shocking New Plan to Control Your Money (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Fed's Shocking New Plan to Control Your Money (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Fed's Shocking New Plan to Control Your Money (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Fed's Shocking New Plan to Control Your Money (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Fed's Shocking New Plan to Control Your Money (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Fed's Shocking New Plan to Control Your Money (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Fed's Shocking New Plan to Control Your Money (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Fed's Shocking New Plan to Control Your Money (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Most-Downgraded Stocks  
NASDAQ:ILMN

Illumina - ILMN Earnings Date, Estimates & Call Transcripts

$217.82
-2.18 (-0.99%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$216.50
▼
$221.56
50-Day Range
$194.01
▼
$228.15
52-Week Range
$173.45
▼
$371.16
Volume
677,179 shs
Average Volume
1.36 million shs
Market Capitalization
$34.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$249.40

Earnings Summary

Upcoming
Earnings Date
May. 4Estimated
Actual EPS
(Feb. 7)
$0.14 Missed By -$0.11
Consensus EPS
(Feb. 7)
$0.25
Last Year's Q1 EPS
(2/10/2022)
$0.75
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ILMN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ILMN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Illumina Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20232$0.01$1.33$0.67 
Q2 20232$0.36$1.33$0.85 
Q3 20232$0.47$1.49$0.98 
Q4 20232$0.66$1.50$1.08 
FY 20238$1.50$5.65$3.58 
Q1 20241$0.72$0.72$0.72 
Q2 20241$0.77$0.77$0.77 
Q3 20241$0.86$0.86$0.86 
Q4 20241$0.94$0.94$0.94 
FY 20244$3.29$3.29 $3.29

ILMN Earnings Date and Information

Illumina last posted its quarterly earnings data on February 7th, 2023. The life sciences company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.25 by $0.11. The business earned $1.08 billion during the quarter, compared to analysts' expectations of $1.07 billion. Its revenue for the quarter was down 9.2% compared to the same quarter last year. Illumina has generated ($28.00) earnings per share over the last year (($28.00) diluted earnings per share). Earnings for Illumina are expected to grow by 153.19% in the coming year, from $1.41 to $3.57 per share. Illumina has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 4th, 2023 based off prior year's report dates.

Illumina Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/4/2023
(Estimated)		        
2/7/2023Q4 2022$0.25$0.14($0.11)$1.17$1.07 billion$1.08 billion    
11/3/2022Q3 2022$0.29$0.34+$0.05$24.94$1.10 billion$1.12 billion
8/11/2022Q2 2022$0.63$0.57($0.06)$4.54$1.22 billion$1.16 billion      
5/5/2022Q1 2022$0.87$1.07+$0.20$1.59$1.22 billion$1.22 billion    
2/10/2022Q4 2021$0.50$0.75+$0.25$0.79$1.12 billion$1.19 billion    
11/4/20219/30/2021$1.24$1.45+$0.21$0.82$1.04 billion$1.11 billion    
8/5/20216/30/2021$1.36$1.87+$0.51$2.48$1.01 billion$1.13 billion    
4/27/20213/31/2021$1.36$1.89+$0.53$2.78$1.08 billion$1.09 billion  
2/11/202112/31/2020$1.11$1.22+$0.11$0.69$949.65 million$953.00 million  
10/29/20209/30/2020$0.77$1.02+$0.25$0.83$713.97 million$794.00 million  
8/6/20206/30/2020$0.67$0.62($0.05)$0.92$682.07 million$633.00 million  
4/30/20203/31/2020$1.25$1.64+$0.39$2.11$857.92 million$859.00 million  
1/29/2020Q4 2019$1.58$1.70+$0.12$1.79$950.16 million$953.00 million  
10/24/2019Q3 19$1.40$1.93+$0.53$2.28$872.65 million$907.00 million  
7/29/20196/30/2019$1.32$1.35+$0.03$0.71$835.12 million$838.00 million  
4/25/20193/31/2019$1.34$1.60+$0.26$1.63$838.70 million$846.00 million    
1/29/201912/31/2018$1.36$1.32($0.04)$1.23$865.33 million$867.00 million  
10/23/20189/30/2018$1.26$1.52+$0.26$1.71$825.65 million$853.00 million    
7/30/2018Q2 2018$1.11$1.43+$0.32$1.45$786.88 million$830.00 million  
4/24/2018Q1 2018$1.02$1.45+$0.43$1.49$744.30 million$782.00 million  
1/30/2018Q4 2017$1.22$1.44+$0.22$2.42$752.04 million$778.00 million  
10/24/2017Q3 2017$0.99$1.11+$0.12$1.11$692.77 million$714.00 million
8/1/2017Q2 2017$0.68$0.82+$0.14$0.77$642.38 million$662.00 million  
4/25/2017Q1 2017$0.64$0.64($1.24)$590.51 million$598.00 million
1/31/2017Q416$0.82$0.85+$0.03$0.86$612.50 million$619.00 million  
11/1/2016Q316$0.87$0.97+$0.10$1.07$628.06 million$607.00 million  
7/26/2016Q2$0.73$0.86+$0.13$0.90$31.91 million$600.00 million  
5/3/2016Q1$0.74$0.71($0.03)$0.82$596.33 million$572.00 million  
2/2/2016Q415$0.82$0.81($0.01)$0.92$576.39 million$591.50 million  
10/20/2015Q315$0.79$0.80+$0.01$0.81$568.60 million$550.00 million  
7/21/2015Q215$0.77$0.80+$0.03$0.91$541.05 million$539.00 million  
4/21/2015Q115$0.72$0.91+$0.19$0.90$524.35 million$539.00 million  
1/27/2015Q414$0.78$0.87+$0.09$0.71$503.83 million$512.00 million  
10/20/2014Q314$0.56$0.77+$0.21$0.91$451.20 million$481.00 million  
7/23/2014Q214$0.51$0.57+$0.06$0.83$426.50 million$448.00 million  
4/22/2014Q114$0.44$0.53+$0.09$0.66$391.50 million$421.00 million  
1/28/2014Q4 2013$0.44$0.45+$0.01$0.34$382.06 million$387.00 million  
10/21/2013Q3 2013$0.40$0.45+$0.05$0.68$343.42 million$357.00 million  
7/23/2013Q2 2013$0.39$0.43+$0.04$0.60$331.77 million$346.09 million  
4/22/2013Q1 2013$0.38$0.46+$0.08$1.10$310.64 million$330.96 million  
1/28/2013Q4 2012$0.41$0.42+$0.01$303.13 million$309.30 million  
10/23/2012$0.39$0.41+$0.02  
7/24/2012$0.36$0.40+$0.04
4/23/2012$0.32$0.36+$0.04
2/7/2012$0.30$0.35+$0.05
10/25/2011$0.23$0.22($0.01)
7/26/2011Q2 2011$0.36$0.38+$0.02$0.54
4/26/2011$0.31$0.35+$0.04
2/8/2011$0.29$0.29
10/26/2010Q3 2010$0.24$0.30+$0.06$0.36
7/27/2010Q2 2010$0.23$0.26+$0.03$0.31
4/28/2010Q1 2010$0.19$0.21+$0.02$0.26
2/4/2010Q4 2009$0.19$0.20+$0.01$0.31
10/27/2009Q3 2009$0.20$0.17($0.03)$0.22
7/21/2009Q2 2009$0.18$0.18$0.18
4/21/2009Q1 2009$0.19$0.19$0.24
2/3/2009Q4 2008$0.17$0.24+$0.07$0.26
10/21/2008Q3 2008$0.17$0.17$0.40
7/22/2008Q2 2008$0.14$0.15+$0.01$0.18
4/22/2008Q1 2008$0.12$0.12$0.13
2/4/2008Q4 2007$0.12$0.15+$0.03$0.34












Illumina Earnings - Frequently Asked Questions

When is Illumina's earnings date?

Illumina has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 4th, 2023 based off last year's report dates. Learn more on ILMN's earnings history.

Did Illumina beat their earnings estimates last quarter?

In the previous quarter, Illumina (NASDAQ:ILMN) missed the analysts' consensus estimate of $0.25 by $0.11 with a reported earnings per share (EPS) of $0.14. Learn more on analysts' earnings estimate vs. ILMN's actual earnings.

How can I listen to Illumina's earnings conference call?

The conference call for Illumina's latest earnings report can be listened to online. Listen to Conference Call

How can I read Illumina's conference call transcript?

The conference call transcript for Illumina's latest earnings report can be read online. Read Transcript

How much revenue does Illumina generate each year?

Illumina (NASDAQ:ILMN) has a recorded annual revenue of $4.58 billion.

How much profit does Illumina generate each year?

Illumina (NASDAQ:ILMN) has a recorded net income of -$4.40 billion. ILMN has generated -$28.00 earnings per share over the last four quarters.

What is Illumina's price-to-earnings ratio?

Illumina (NASDAQ:ILMN) has a forward price-to-earnings ratio of 154.48. The price/earnings-to-growth ratio is 8.02.

What is Illumina's EPS forecast for next year?

Illumina's earnings are expected to grow from $1.41 per share to $3.57 per share in the next year, which is a 153.19% increase.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:ILMN) was last updated on 3/28/2023 by MarketBeat.com Staff